Charles River Laboratories (CRL) to Acquire Cognate BioServices for $875 Million
Go back to Charles River Laboratories (CRL) to Acquire Cognate BioServices for $875 Million| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 280.76 -7.74 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.50 | 52 Week High | $89.18 | |||
| Open | $285.60 | 52 Week Low | $65.70 | |||
| Day High | $285.94 | P/E | 130.59 | |||
| Day Low | $280.16 | EPS | $2.15 | |||
| Volume | 729,156 | |||||
